Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
| WAINUA | astrazeneca canada inc | Marketed | Oct 7, 2024 | Marketed |
| HYDRALAZINE HYDROCHLORIDE INJECTION, USP | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
| LIDOCAINE INJECTION BP | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
| LIDOCAINE INJECTION BP | eugia pharma inc. | Marketed | Oct 7, 2024 | Marketed |
| ICATIBANT INJECTION | Jamp Pharma Corporation | Marketed | Oct 4, 2024 | Marketed |
| JAMP GLICLAZIDE-MR | Jamp Pharma Corporation | Marketed | Oct 4, 2024 | Marketed |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | EUGIA PHARMA INC. | Marketed | Oct 2, 2024 | Marketed |
| MINT-METFORMIN XR | mint pharmaceuticals inc | Marketed | Oct 2, 2024 | Marketed |
| MAR-METFORMIN XR | marcan pharmaceuticals inc | Marketed | Oct 2, 2024 | Marketed |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | eugia pharma inc. | Marketed | Oct 2, 2024 | Marketed |
| AXBERI | baxter corporation | Marketed | Oct 1, 2024 | Marketed |
| AXBERI | baxter corporation | Marketed | Oct 1, 2024 | Marketed |
| AXBERI HP | baxter corporation | Marketed | Oct 1, 2024 | Marketed |
| JAMP SUMATRIPTAN DF | Jamp Pharma Corporation | Marketed | Sep 30, 2024 | Marketed |
| JAMP SUMATRIPTAN DF | Jamp Pharma Corporation | Marketed | Sep 30, 2024 | Marketed |
| JAMP SUMATRIPTAN DF | Jamp Pharma Corporation | Marketed | Sep 30, 2024 | Marketed |
| JAMP CEFUROXIME | Jamp Pharma Corporation | Marketed | Sep 27, 2024 | Marketed |
| PMS-PALBOCICLIB | Pharmascience Inc | Marketed | Sep 27, 2024 | Marketed |
| PMS-PALBOCICLIB | Pharmascience Inc | Marketed | Sep 27, 2024 | Marketed |
